Novo Nordisk A/S Taps Stem Cells In Hunt For Diabetes Cure

This article was originally published here

LONDON (Reuters) – Danish drugmaker Novo Nordisk A/S is turning to stem cells in the hunt for a cure for diabetes.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply